Literature DB >> 18187721

Should heroin be prescribed to heroin misusers? No.

Neil McKeganey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18187721      PMCID： PMC2190263          DOI： 10.1136/bmj.39422.503241.AD

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Seven doctors accused of over-prescribing heroin.

Authors:  Owen Dyer
Journal:  BMJ       Date:  2004-02-28

2.  Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis.

Authors:  Carlos Nordt; Rudolf Stohler
Journal:  Lancet       Date:  2006-06-03       Impact factor: 79.321

3.  Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS).

Authors:  Shane Darke; Joanne Ross; Katherine L Mills; Anna Williamson; Alys Havard; Maree Teesson
Journal:  Addict Behav       Date:  2007-01-23       Impact factor: 3.913

4.  Evaluation of heroin maintenance in controlled trial.

Authors:  R L Hartnoll; M C Mitcheson; A Battersby; G Brown; M Ellis; P Fleming; N Hedley
Journal:  Arch Gen Psychiatry       Date:  1980-08

5.  Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials.

Authors:  Wim van den Brink; Vincent M Hendriks; Peter Blanken; Maarten W J Koeter; Barbara J van Zwieten; Jan M van Ree
Journal:  BMJ       Date:  2003-08-09
  5 in total
  3 in total

1.  Heroin prescription to misusers: Treat patients, not communities.

Authors:  Andrew J Ashworth
Journal:  BMJ       Date:  2008-01-26

2.  Heroin prescription to misusers: Prejudice based medicine?

Authors:  Roger Weeks
Journal:  BMJ       Date:  2008-01-26

Review 3.  Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?

Authors:  Maria Paz Garcia-Portilla; Maria Teresa Bobes-Bascaran; Maria Teresa Bascaran; Pilar Alejandra Saiz; Julio Bobes
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.